Connect with us
The Indian pharmaceutical and biotechnology sector is transforming through acquisitions and innovation. Sun Pharma plans to acquire Innovcare Lifesciences to expand in nutritional supplements, and has...
Sartorius Stedim Biotech reported solid H1 2026 results, with revenue reaching €1.527 billion and EBITDA rising to €479 million. Growth was driven by recurring demand and...
After a downturn, biotechnology is regaining attention as major pharmaceutical companies invest heavily in innovative platforms to offset patent losses and boost growth. Acquisitions are rising...
Legend Biotech's stock reflects demand for innovative CAR-T cancer therapies. The US biotech focuses on commercializing Carvykti with partner Janssen while expanding its pipeline. Approved revenue...
Emily.AI, Quirónsalud’s explainable AI medical device, became a global finalist at the AI for Good Summit 2026 after competing with 500+ projects. Developed in Catalonia, it...
A CSIC-UMH study identifies heightened interferon signaling as a key factor in women’s greater Alzheimer’s vulnerability. Analysis of human brain tissue and animal models showed stronger...
Biovalley Investments Partner (BIP) sold its entire stake in BIC Incubatori FVG to Innova, both Trieste-based firms and longtime users of the incubator. BIP will continue...
Facing declining biotech financing and competitiveness, the European Commission has proposed the Biotech Act to boost investment, streamline regulation, and expand production. With Europe lagging behind...
A blood test detecting tumor DNA may personalize treatment for colorectal cancer patients with liver metastases after surgery. The GALAXY study shows patients with detectable DNA...
Karyopharm Therapeutics is a US biotechnology company focused on developing innovative cancer and serious disease therapies. Its value depends heavily on clinical trial success, regulatory approvals,...
 |
|
 |  |
 |
|